SCHEMBL12296156

SCHEMBL12296156

SC1=NCCC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9909114 0.69
SCHEMBL12774875 0.67
SCHEMBL15940521 0.67
SCHEMBL19886832 0.67
SCHEMBL8882266 0.67
SCHEMBL14052202 0.62
SCHEMBL19622241 0.62
SCHEMBL15268205 0.62
SCHEMBL13956304 0.59
SCHEMBL1833000 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2717916-B1 PROTEIN-POLYMER-DRUG CONJUGATES MERSANA THERAPEUTICS INC (US) 2017-03-08 EP disclosed
WO-2013082196-A1 bFGF-POLYMER CONJUGATES, METHODS FOR MAKING THE SAME AND APPLICATIONS THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-06-06 WO disclosed
WO-2012171020-A1 PROTEIN-POLYMER-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. (US) 2012-12-13 WO disclosed
WO-2012158795-A1 PYRAZOLOPYRIMIDINE DERIVATIVES AS TYROSINE KINASE INHIBITORS PRINCIPIA BIOPHARMA INC. (US) 2012-11-22 WO disclosed
WO-2011120053-A1 MODIFIED POLYMERS FOR DELIVERY OF POLYNUCLEOTIDES, METHOD OF MANUFACTURE, AND METHODS OF USE THEREOF MERSANA THERAPEUTICS, INC. (US) 2011-09-29 WO disclosed
US-20080014149-A1 Methods and Compositions for Imaging and Biomedical Applications EMORY UNIVERSITY 2008-01-17 US disclosed